What is Azenta's cash and cash equivalents, end of period?

Azenta (AZTA) reported cash and cash equivalents, end of period of $249.29M in Q1 2026.

Azenta AZTA Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Labcorp HoldingsLH

——

BioLife SolutionsBLFS

——

Other financials

Income statement

See full

Revenue$144.8M+1.0%

Gross profit$62.0M-1.2%

Operating income-$165.8M-811%

Net income-$160.8M-237%

EPS (diluted)-$3.49-236%

Balance sheet

See full

Cash & equivalents$125.2M—

Total debt$55.7M—

Total equity$1.6B-8.3%

Total assets$1.9B—

Cash flow

See full

Operating cash flow$13.5M-6.2%

CapEx$7.4M-0.1%

Free cash flow$6.1M-12.7%

Valuation

See full

Market cap$1.14B-16.3%

Enterprise value$1.07B—

P/S1.9×-0.2×

Profitability

See full

Gross margin40%-1.0pp

Operating margin-31.6%-59.7pp

Net margin-29.1%-80.7pp

FCF margin8.6%—

Returns & leverage

See full

Return on equity-10.7%-22.4pp

Debt / equity0×—

Current ratio2.8×—

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Azenta's cash and cash equivalents, end of period?: Azenta (AZTA) reported cash and cash equivalents, end of period of $249.29M in Q1 2026.